Myriad Genetics Articles
US Supreme Court knocks back Myriad Genetics patents
1 April 2012
Recent decision outlawing gene patents has limited applicability, says NY patent attorney, Ted Sabety
21 April 2010
Showing 1-5 of 5 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
